Wolfgang Miesbach/LinkedIn
Nov 19, 2026, 11:51
Wolfgang Miesbach: Beyond Episomal Gene Therapy in Haemophilia B
Wolfgang Miesbach, Head of Hemostasis/Hemophilia Center at Medical Clinic 2 at University Hospital Frankfurt, shared a post on LinkedIn:
“Beyond episomes: targeted gene insertion for haemophilia B. At ESGCT2026 Meagan O’Brien (Regeneron) presented the CRISPR-based targeted F9 insertion platform developed with Intellia Therapeutics. One of the talks that made me think about children.
Why go further than what we have?
- The one approved liver-directed AAV therapy for haemophilia B works through non-integrating episomes.
- Episomes can be lost when hepatocytes divide, a real concern in a liver that is still growing.
- It relies on the hyperactive Padua variant to compensate for the low expression seen with wild-type F9.
- Long-term durability in children therefore remains unknown.
The approach: two components, same day
- rAAV8 delivers a promoterless wild-type F9 template.
- An LNP then delivers Cas9 plus a single guide RNA, targeting albumin intron 1.
- F9 is inserted at the ALB locus and expressed under the albumin promoter.
- Wild-type FIX, not Padua, and an approach that could be suitable at any age.
- Supporting rodent and primate data were shown; the manuscript is under review, so I will leave the figures to the authors.
Already in the clinic
- BEYOND-9 (NCT06379789) is a two-part, open-label phase 1/2 study, currently recruiting.
- Dose escalation and confirmation in adults first, then expansion to adolescents and children from two years of age.
- Males with severe or moderately severe haemophilia B on FIX prophylaxis.”

Other posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Nov 19, 2026, 11:18A First Look at WFH CCS 2027
-
Nov 19, 2026, 10:58Does a Higher Measured Factor Level Always Mean Better Protection Against Joint Bleeds? – Global Hemophilia Report
-
Nov 19, 2026, 10:43Strengthening Plasma Management and Patient Access Across Eastern Europe – ISBT
-
Nov 19, 2026, 10:32Rana Al-Hrout: The Hemodilution Trap – Accurate Blast Assessment in Bone Marrow Biopsies
-
Nov 19, 2026, 10:29Maria Panagiota Terzi: Presenting Research on Coagulation Biomarkers in Acute Myocardial Infarction
-
Nov 19, 2026, 10:21Paola Ranalli: Hemophilia and von Willebrand Disease Advancing Care Through Multidisciplinary Collaboration
-
Nov 19, 2026, 10:11Rana Al-Hrout: Iron Deficiency in Heart Failure – Does It Matter Even Without Anemia?
-
Nov 19, 2026, 10:08Christina Rolling: CAR T-Cell Therapy and Coagulation Disturbances Understanding Severe Hypofibrinogenemia
-
Nov 19, 2026, 09:34Dahlia R.: Immature Platelet Fraction Understanding the Cause of Low Platelet Counts